Clinical Trials Logo

Papilloma clinical trials

View clinical trials related to Papilloma.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT05736718 Enrolling by invitation - Clinical trials for Human Papilloma Virus

Engaging Clinical Champions to Improve HPV Vaccination

Start date: March 8, 2023
Phase: N/A
Study type: Interventional

This trial will compare two ways to improve communication about HPV vaccination in primary care. The research team will work with primary care clinics. Some clinics will receive communication training from an outside expert. Other clinics will receive the same training from a vaccine champion from their healthcare system.

NCT ID: NCT05600283 Enrolling by invitation - Clinical trials for Human Papilloma Virus

Patient Self-sampling of HPV to Screen for Cervical Cancer

Start date: November 16, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cervical swab samples to determine the laboratory HPV testing accuracy of the self-collection swab.

NCT ID: NCT04905030 Enrolling by invitation - Cervical Cancer Clinical Trials

Education, Immigration and HPV Vaccination: an Informational Randomized Trial

Start date: April 28, 2021
Phase: N/A
Study type: Interventional

Counteracting misinformation on childhood vaccines remains a priority for public health in industrialized countries. Previous research showed that misinformation-induced vaccine hesitancy particularly concerns very highly or very lowly educated parents, and, especially in Europe, specific groups of immigrants. Misinformation framing directly targets specific sub-population of parents by exploiting different cognitive biases, and specific concerns based on cultural norms: this project aims at testing the effectiveness of similar framing techniques applied to positive information on the HPV vaccine by conducting a Randomized Controlled Trial in Stockholm, Sweden. It randomizes emotionally and scientifically/statistically framed information addressing the specific concerns reported by previous literature.